Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ARIAD reaches 50% enrollment in Phase 3 EPIC trial
ARIAD reaches 50% enrollment in Phase 3 EPIC trial
ARIAD reaches 50% enrollment in Phase 3 EPIC trial
Submitted by
admin
on September 4, 2013 - 9:31am
Source:
The Fly on the Wall
News Tags:
Ariad Pharmaceuticals
clinical trials
chronic myeloid leukemia
Iclusig
Headline:
ARIAD reaches 50% enrollment in Phase 3 EPIC trial
Do Not Allow Advertisers to Use My Personal information
